Biosimilars in Pharmacy Benefits: Why Formularies Must Evolve
For many self-funded employers, pharmacy benefits can feel like a moving target. One year, costs look manageable. The next, a...
For many self-funded employers, pharmacy benefits can feel like a moving target. One year, costs look manageable. The next, a...
For employers and benefits advisors, navigating the pharmacy benefits landscape space requires more than clinical and industry knowledge – it demands clarity, transparency,...
A massive regulatory shift is quickly approaching, and it’s set to impact how hospital and health system HR leaders manage pharmacy benefits for their employees. In...
GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro have fundamentally changed the management of obesity and type 2 diabetes. These medications deliver meaningful weight loss...
With the conclusion of the first quarter of 2026, transparency and affordability continue to dominate the conversation around pharmacy benefits regulation....
As a self-funded employer, figuring out how best to manage your pharmacy benefits is one of your most important choices. Do...
The world of pharmacy benefits managers (PBMs) is undergoing a significant transformation. Driven by a nationwide push for greater transparency and...
It seems impossible to discuss pharmacy benefits today without mentioning one class of drugs: GLP-1s. They are in news headlines,...
It has only been a few short years since GLP-1 drugs exploded in popularity, yet their impact on the healthcare...
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.